Lithium Carbonate

Basic Information

Item Value
DrugBank ID DB14509
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 34

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 pseudoachondroplasia KG + DL
2 acromesomelic dysplasia, Hunter-Thompson type KG + DL
3 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
4 brachyolmia KG + DL
5 myosclerosis KG + DL
6 brachyolmia-amelogenesis imperfecta syndrome KG + DL
7 brachydactyly-syndactyly syndrome KG + DL
8 Behr syndrome KG + DL
9 WHIM syndrome KG + DL
10 combined immunodeficiency due to moesin deficiency KG + DL
11 myofascial pain syndrome KG + DL
12 rheumatoid factor-positive polyarticular juvenile idiopathic arthritis KG + DL
13 rheumatoid nodulosis KG + DL
14 juvenile chronic polyarthritis KG + DL
15 idiopathic granulomatous myositis KG + DL
16 myositis fibrosa KG + DL
17 tendinitis KG + DL
18 inclusion body myositis KG + DL
19 restless legs syndrome KG + DL
20 fibromyalgia KG + DL
21 acne (disease) KG + DL
22 trigeminal nerve neoplasm KG + DL
23 gout KG + DL
24 hypotrichosis simplex of the scalp KG + DL
25 facial neuralgia KG + DL
26 combined hyperactive dysfunction syndrome of the cranial nerves KG + DL
27 congenital hypotrichosis milia KG + DL
28 diffuse alopecia areata KG + DL
29 obsolete vascular headache KG + DL
30 vertebral disease KG + DL
31 spondyloarthropathy, susceptibility to KG + DL
32 neuralgia KG + DL
33 ankylosing spondylitis KG + DL
34 leukoplakia KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.